 |
 |
 |
|
FINAL PROGRAMME
Symposium 29
| HALL A4/5 | 11:30 - 12:30 |
| Last minute trials |
| Chairs: | Carl-Gustav Elinder, Stockholm, Sweden |
| Christoph Wanner, Würzburg, Germany |
| Results of Renal-ONTARGET |
Johannes F.E. Mann, Munich, Germany and Roland E. Schmieder, Erlangen, Germany for the ONTARGET investigators |
| Revascularisation for atherosclerotic renovascular disease: results of the ASTRAL trial |
| Philip Kalra, Salford, UK |
| Mycophenolate mofetil or intravenous cyclophosphamide as induction for lupus nephritis: ALMS renal endpoints |
| David Jayne, Cambridge, UK |
| The MPO Study: is it more than an European HEMO study? |
| Francesco Locatelli, Lecco, Italy |